<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>VPT-101 Industry Express Lane - Partner or Compete</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
            background: linear-gradient(135deg, #1f2937 0%, #374151 100%);
            color: white;
            min-height: 100vh;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }

        .header {
            text-align: center;
            margin-bottom: 40px;
            background: linear-gradient(135deg, #dc2626 0%, #b91c1c 100%);
            padding: 40px;
            border-radius: 20px;
        }

        .nav-back {
            text-align: left;
            margin-bottom: 20px;
        }

        .nav-back a {
            color: #f59e0b;
            text-decoration: none;
            font-weight: 600;
            display: inline-flex;
            align-items: center;
            gap: 8px;
            padding: 10px 20px;
            background: rgba(255, 255, 255, 0.1);
            border-radius: 8px;
            transition: all 0.3s ease;
        }

        .nav-back a:hover {
            background: rgba(255, 255, 255, 0.2);
            transform: translateX(-5px);
        }

        .header h1 {
            font-size: 3rem;
            margin-bottom: 10px;
        }

        .warning {
            background: #dc2626;
            color: white;
            padding: 20px;
            border-radius: 10px;
            margin-bottom: 30px;
            text-align: center;
            font-size: 1.3rem;
            font-weight: 600;
        }

        .express-lane {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
            gap: 30px;
            margin-bottom: 40px;
        }

        .lane-card {
            background: rgba(255, 255, 255, 0.1);
            backdrop-filter: blur(10px);
            padding: 30px;
            border-radius: 15px;
            border: 2px solid #f59e0b;
        }

        .lane-card h2 {
            color: #f59e0b;
            margin-bottom: 20px;
            font-size: 1.8rem;
        }

        .benefits-list {
            list-style: none;
            margin-bottom: 20px;
        }

        .benefits-list li {
            padding: 10px 0;
            border-bottom: 1px solid rgba(255, 255, 255, 0.1);
        }

        .benefits-list li:before {
            content: "‚úÖ ";
            color: #10b981;
        }

        .cta-button {
            display: inline-block;
            background: #dc2626;
            color: white;
            padding: 15px 30px;
            border-radius: 10px;
            text-decoration: none;
            font-weight: 600;
            font-size: 1.2rem;
            transition: all 0.3s ease;
        }

        .cta-button:hover {
            background: #b91c1c;
            transform: translateY(-2px);
        }

        .regulatory-kit {
            background: linear-gradient(135deg, #10b981 0%, #059669 100%);
            padding: 40px;
            border-radius: 20px;
            margin-bottom: 40px;
        }

        .kit-title {
            font-size: 2.5rem;
            margin-bottom: 20px;
            text-align: center;
        }

        .kit-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin-top: 30px;
        }

        .kit-item {
            background: rgba(255, 255, 255, 0.2);
            padding: 20px;
            border-radius: 10px;
            text-align: center;
        }

        .kit-item h3 {
            margin-bottom: 10px;
            color: #fbbf24;
        }

        .consortium-pressure {
            background: linear-gradient(135deg, #7c3aed 0%, #5b21b6 100%);
            padding: 40px;
            border-radius: 20px;
            text-align: center;
        }

        .pressure-title {
            font-size: 2.5rem;
            margin-bottom: 20px;
        }

        .pressure-stats {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .stat-card {
            background: rgba(255, 255, 255, 0.2);
            padding: 20px;
            border-radius: 10px;
        }

        .stat-number {
            font-size: 2rem;
            font-weight: 800;
            color: #fbbf24;
        }

        @keyframes pulse {
            0% { transform: scale(1); }
            50% { transform: scale(1.05); }
            100% { transform: scale(1); }
        }

        .pulse {
            animation: pulse 2s infinite;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="nav-back">
            <a href="index.html">‚Üê Back to Home</a>
        </div>
        <div class="header">
            <h1>üè¢ VPT-101 Industry Express Lane</h1>
            <p><strong>"Partner with us or compete against the world"</strong></p>
        </div>

        <div class="warning pulse">
            ‚ö†Ô∏è WARNING: Big Pharma's "Blockbuster vs Netflix" moment is here. 
            The open-source revolution in medicine has begun.
        </div>

        <div class="express-lane">
            <div class="lane-card">
                <h2>üöÄ Fast-Track Licensing</h2>
                <ul class="benefits-list">
                    <li>Exclusive commercial rights for consortium members</li>
                    <li>Pre-negotiated terms with regulatory bodies</li>
                    <li>Shared IP protection and enforcement</li>
                    <li>Priority access to clinical trial data</li>
                    <li>Reduced development timeline by 60%</li>
                </ul>
                <a href="mailto:screball7605@aol.com" class="cta-button">
                    üö® SECURE LICENSING NOW
                </a>
            </div>

            <div class="lane-card">
                <h2>üí∞ Shared Development Costs</h2>
                <ul class="benefits-list">
                    <li>Split R&D costs across multiple companies</li>
                    <li>Shared manufacturing infrastructure</li>
                    <li>Collective bargaining power with suppliers</li>
                    <li>Risk mitigation through consortium</li>
                    <li>Faster time-to-market through collaboration</li>
                </ul>
                <a href="mailto:screball7605@aol.com" class="cta-button">
                    üí∞ JOIN DEVELOPMENT POOL
                </a>
            </div>
        </div>

        <div class="regulatory-kit">
            <h2 class="kit-title">üìã Regulatory Fast-Track Kit</h2>
            <p style="text-align: center; font-size: 1.2rem; margin-bottom: 30px;">
                Remove every barrier to clinical trials. Pre-filled templates and FDA packages ready for immediate submission.
            </p>
            
            <div class="kit-grid">
                <div class="kit-item">
                    <h3>üìÑ Pre-filled IND Templates</h3>
                    <p>FDA-ready Investigational New Drug applications with all required sections completed</p>
                </div>
                <div class="kit-item">
                    <h3>üèõÔ∏è FDA Meeting Request Packages</h3>
                    <p>Complete packages for Pre-IND, End-of-Phase 1, and End-of-Phase 2 meetings</p>
                </div>
                <div class="kit-item">
                    <h3>üìä Toxicology Matrix</h3>
                    <p>OECD and GLP compliant safety assessment frameworks and checklists</p>
                </div>
                <div class="kit-item">
                    <h3>üè≠ Manufacturing SOPs</h3>
                    <p>GMP-compliant production protocols for scale-up and commercialization</p>
                </div>
                <div class="kit-item">
                    <h3>üåç EMA Templates</h3>
                    <p>European Medicines Agency submission packages and regulatory pathways</p>
                </div>
                <div class="kit-item">
                    <h3>‚ö° Fast-Track Designation</h3>
                    <p>Priority review and accelerated approval pathway documentation</p>
                </div>
            </div>

            <div style="text-align: center; margin-top: 30px;">
                <a href="regulatory/FDA_submission_template.html" class="cta-button" style="margin-right: 10px;">
                    üìÑ VIEW REGULATORY TEMPLATE
                </a>
                <a href="regulatory/FDA_submission_template.md" class="cta-button" style="background: #10b981;">
                    üì• DOWNLOAD MARKDOWN
                </a>
            </div>
        </div>

        <div class="consortium-pressure">
            <h2 class="pressure-title">üè¢ VPT-101 Consortium</h2>
            <p style="font-size: 1.3rem; margin-bottom: 30px;">
                <strong>Early adopters get preferred licensing terms, shared development costs, and first-to-market advantage.</strong>
            </p>

            <div class="pressure-stats">
                <div class="stat-card">
                    <div class="stat-number">1</div>
                    <div>Repository</div>
                </div>
                <div class="stat-card">
                    <div class="stat-number">Ready</div>
                    <div>Framework</div>
                </div>
                <div class="stat-card">
                    <div class="stat-number">Available</div>
                    <div>Protocols</div>
                </div>
                <div class="stat-card">
                    <div class="stat-number">Open</div>
                    <div>Access</div>
                </div>
            </div>

            <p style="font-size: 1.2rem; margin: 30px 0;">
                <strong>Research Development Timeline:</strong><br>
                Phase 1: Framework Release (Complete)<br>
                Phase 2: Community Building (In Progress)<br>
                Phase 3: Validation Studies (Planned)<br>
                Phase 4: Clinical Translation (Future)
            </p>

            <a href="mailto:screball7605@aol.com" class="cta-button">
                üö® JOIN THE CONSORTIUM NOW
            </a>
        </div>
    </div>
</body>
</html> 